|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Investment properties, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Investment in marketable securities | ||||||||||||||||||||
| Rent and other receivables, net of allowance of $0 as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Equity investment | ||||||||||||||||||||
| Unbilled rent | ||||||||||||||||||||
| Intangible lease assets, net | ||||||||||||||||||||
| Other intangible assets | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Liabilities associated with assets held for sale | ||||||||||||||||||||
| Intangible lease liabilities, net | ||||||||||||||||||||
| Line of credit, short term, net | ||||||||||||||||||||
| Mortgages payable, net | ||||||||||||||||||||
| Mortgages payable, net, associated with assets held for sale | ||||||||||||||||||||
| Parkway Property | ||||||||||||||||||||
| Total mortgages payable, net, associated with assets held for sale | ||||||||||||||||||||
| Mandatorily redeemable preferred stock, net | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Common stock, $0.01 par value, 750,000,000 shares authorized, 1,628,500 and 1,110,000 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Offering costs | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Hanover Square Property | ||||||||||||||||||||
| Parkway Property | ||||||||||||||||||||
| DST Entities | ||||||||||||||||||||
| Noncontrolling interests - Operating Partnership | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities and Equity | ||||||||||||||||||||
Loading...
